CASE
Boehringer-Ingelheim (Boehringer-Ingelheim) is a pharmaceutical company dedicated to human biopharmaceutical chemistry and animal health products, and is also the world's largest privately-owned pharmaceutical company. The company has 146 subsidiaries and approximately 50,000 employees worldwide, has 20 human pharmaceutical production bases in 11 countries, and achieved net sales of 17.5 billion euros in 2018. Human medicines are the company's largest business. The income of human medicines business reached 12.6 billion euros, accounting for 72% of the group's total revenue.
With 5 R&D centers around the world, with more than 8,100 R&D and medical department employees, Boehringer Ingelheim’s R&D expenditure in 2018 reached a record high of 3.2 billion euros, accounting for more than 18% of annual sales, and is committed to an independent foundation Sexual research.
LISO EXPO Group is a brand marketer focusing on global exhibition industry chain services. It has a number of honors and qualifications in the exhibition industry. It was selected as the first batch of key contact enterprises in the exhibition industry by the Ministry of Commerce. Booth construction service provider. At present, the four CIIEs have served a total of 190+ customers, with a service area of over 25000m²+, ranking first in terms of quantity and area.
lisogroup@lisoexpo.com
19 / F, Nankai building, 1332 Lujiabang Road, Huangpu District, Shanghai
Website record number:沪ICP备19019106号-1 沪公网安备:31010102003165号 |